Back to search results

Using Aspirin to Improve Immunological Features of Ovarian Tumors

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Tiffany Shiles) · Tiffany.Shiles@moffitt.org · 813-745-2948
    Contact: Study coordinator (Jing-Yi Chern, MD) · Jing-Yi.Chern@moffitt.org · 813-745-7205
    Contact: Principal Investigator (Jing-YI Chern, MD)

  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Yukie Bean) · BeanY@ohsu.edu · 503-418-4522
    Contact: Study coordinator (Alberta Barnes) · barnealb@ohsu.edu
    Contact: Principal Investigator (Elizabeth Munro, MD)

  • University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, United States

    Contact: Principal Investigator (Matt Wagar, MD)

  • Inova Schar Cancer Institute, Fairfax, Virginia, United States

    Contact: Study coordinator (Eibhleann Cojocari) · Eibhleann.Cojocari@inova.org · 571-472-0246
    Contact: Principal Investigator (Christina Annunziata, MD)
Study leads

  • Jing-Yi Chern, MD

    Principal Investigator

    Moffitt Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)